Advertisement

GI & Endoscopy

Advertisement

The market for hepatitis C drugs has been closely followed as new — and expensive — treatments have resulted in high cure rates. Now, two additional oral HCV drugs have received FDA approval, according to a Medscape report.

Advertisement